Articles by admin

Yahoo Finance’s Brian Sozzi, Alexis Christoforous, and Dan Howley discuss the backlash Mark Zuckerberg is facing amid civil unrest. …read more […]

Winnie Sun, Sun Group Wealth Partners, joins Yahoo Finance’s The First Trade to discuss where her clients are investing, including technology in the long-term, savings, travel and more. …read more […]

Diamond Hill Capital recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Diamond Hill Small Cap Fund posted a return of -36.17% for the quarter, underperforming its benchmark, the Russell 2000 Index which returned -30.61% in the same quarter. You should check out Diamond Hill Capital’s top 5 […] …read more […]

Narayana Kocherlakota, Former Minneapolis Fed President, joins Yahoo Finance’s Brian Cheung, Brian Sozzi and Alexis Christoforous to discuss what we can expect from the Federal Reserve in the coming weeks. …read more […]

An editor at both the New York Times and Philadelphia Inquirer chose to resign after facing backlash over controversial headlines. Yahoo Finance’s Emily McCormick breaks down the details. …read more […]

Arguably the most controversial on the Street, penny stocks are a hot-button issue. Usually, there isn’t a lot of middle-ground with respect to these tickers priced for less than $5 apiece. Dividing market watchers into two distinct groups, both sides present valid arguments laying out the pros and cons.Sure, there is reason enough to be skeptical. Often, a cheap stock is cheap for a reason, with the low share price potentially reflecting an underlying problem with the business, whether it be poor fundamentals or unbeatable headwinds. That said, a bargain price tag isn’t always indicative of a lost cause. …read more […]

(Bloomberg) — Data on Sarepta Therapeutics Inc.’s experimental gene therapy for a rare type of muscular dystrophy showed that patients receiving a higher dose of the medicine saw greater benefits than those receiving a lower dose, delivering another early-stage win for the drug developer.Three patients with limb-girdle muscular dystrophy Type 2E who got the high dose of Sarepta’s SRP-9003 produced greater levels of the protein beta-sarcoglycan. While patients with the progressive and debilitating muscle-wasting disease normally make very little or none of the protein, the three children showed an average protein expression that was 62% of normal, topping 36% seen …read more […]

Reebok decided to end its partnership with CrossFit due to a controversial tweet by CrossFit founder and CEO. Yahoo Finance’s Emily McCormick shares the details. …read more […]

Yahoo Finance’s Alexis Christoforous, Brian Sozzi, and Anjalee Khemlani discuss a possible merger between Astrazeneca and Gilead Sciences. …read more […]

The Black Lives Matter movement has sparked some monumental changes, with cities making moves to defund police forces. Yahoo Finance’s Alexis Christoforous, Brian Sozzi, and Andy Serwer discuss. …read more […]